Blog Archives

Blog

Enhanced Stereochemistry Features – How to Use Them, and Handle Unknowns and Mixtures

While the V3000 version of MDL’s molfile specification is not necessarily new in the field…

CertaraSeptember 12, 2021

Blog

Pushing the limit of logP prediction accuracy: ChemAxon’s results for the SAMPL 6 blind challenge

SAMPL (Statistical Assessment of the Modeling of Proteins and Ligands) challenges are designed to benchmark…

CertaraSeptember 2, 2021

Blog

Pediatric Drug Development: Optimizing Extrapolation

Drug development in pediatrics continues to be a substrate for the application of innovative tools…

CertaraSeptember 1, 2021

Blog

Gene Therapy Based Precision Medicine Therapeutics: Clinical Pharmacology & Translational Science Considerations

The era of gene therapy may have started a couple of decades ago, but approvals…

CertaraAugust 13, 2021

Blog

Succeeding in Value Communication: Introduction

Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…

CertaraAugust 5, 2021

Blog

Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success

Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…

CertaraJuly 8, 2021

Blog

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…

CertaraJune 25, 2021

Blog

Top 10 Benefits to Integrating the Simcyp PBPK Simulator into your Drug Development Program

Per US FDA’s recent paper on the topic, Physiologically based Pharmacokinetic (PBPK) modeling & simulation…

CertaraJune 22, 2021

Blog

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…

CertaraJune 18, 2021

Blog

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

Every FDA Advisory Committee meeting is unique, and the Cellular, Tissue, and Gene Therapies Advisory…

CertaraJune 15, 2021

Blog

Enhanced Stereochemistry Features – How to Use Them, and Handle Unknowns and Mixtures

Pushing the limit of logP prediction accuracy: ChemAxon’s results for the SAMPL 6 blind challenge

Pediatric Drug Development: Optimizing Extrapolation

Gene Therapy Based Precision Medicine Therapeutics: Clinical Pharmacology & Translational Science Considerations

Succeeding in Value Communication: Introduction

Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

Top 10 Benefits to Integrating the Simcyp PBPK Simulator into your Drug Development Program

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

Newsletter sign up

Quick links

Solutions

Contact